A nonrandomized phase 2 trial of oral thymic peptides in hospitalized patients with Covid-19

Data Availability
Plan to Share Individual Participant Data (IPD): Yes Plan Description: All of the individual participant data collected during the trial, after deidentification. Supporting Materials: Study Protocol Supporting Materials: Statistical Analysis Plan (SAP) Supporting Materials: Informed Consent Form (ICF) Supporting Materials: Clinical Study Report (CSR) Supporting Materials: Analytic Code Time Frame: Beginning 3 months and ending 5 years following article publication. Email addresses hramos{at}unicah.edu; hmramos{at}uc.cl Access Criteria: Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. For individual participant data meta-analysis.
Subject Area
- Addiction Medicine (227)
- Allergy and Immunology (502)
- Anesthesia (110)
- Cardiovascular Medicine (1234)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10015)
- Gastroenterology (499)
- Genetic and Genomic Medicine (2448)
- Geriatric Medicine (236)
- Health Economics (479)
- Health Informatics (1638)
- Health Policy (751)
- Hematology (248)
- HIV/AIDS (532)
- Medical Education (252)
- Medical Ethics (74)
- Nephrology (268)
- Neurology (2278)
- Nursing (139)
- Nutrition (350)
- Oncology (1245)
- Ophthalmology (375)
- Orthopedics (133)
- Otolaryngology (226)
- Pain Medicine (155)
- Palliative Medicine (50)
- Pathology (324)
- Pediatrics (729)
- Primary Care Research (282)
- Public and Global Health (4829)
- Radiology and Imaging (834)
- Respiratory Medicine (651)
- Rheumatology (283)
- Sports Medicine (226)
- Surgery (266)
- Toxicology (44)
- Transplantation (125)
- Urology (99)